Group One Trading, L.P. Vertex Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

$2.68 Billion
Q1 2024

A detailed history of Group One Trading, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 15,133 shares of VRTX stock, worth $6.89 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

15,133

Holding current value

$6.89 Million

% of portfolio

0.24%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $6.17 Million - $6.75 Million	15,133 New	15,133 $6.33 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $5.78 Million - $6.5 Million	20,221 Added 81.27%	45,103 $13 Million
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $1.16 Million - $1.29 Million	4,222 Added 20.44%	24,882 $7.2 Million
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $1.26 Million - $1.56 Million	5,344 Added 34.89%	20,660 $5.82 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $18.4 Million - $21.7 Million	-83,121 Reduced 84.44%	15,316 $4 Million

Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $4.69 Million - $5.92 Million	26,514 Added 36.86%	98,437 $21.6 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $972,613 - $1.09 Million	5,362 Added 8.06%	71,923 $13 Million
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $3.06 Million - $3.61 Million	-16,319 Reduced 19.69%	66,561 $13.4 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $3.39 Million - $3.95 Million	-16,367 Reduced 16.49%	82,880 $17.8 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $20.5 Million - $27.4 Million	99,247 New	99,247 $23.5 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $2.63 Million - $3.45 Million	-11,669 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $2.33 Million - $2.89 Million	11,669 New	11,669 $2.78 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $951,988 - $1.11 Million	-6,533 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$151.6 - $177.13 $2.55 Million - $2.98 Million	-16,837 Reduced 72.05%	6,533 $1.07 Million
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $3.21 Million - $3.64 Million	23,370 New	23,370 $3.5 Million
Q3 2017 Nov 15, 2017	SELL	$148.13 - $162.24 $2.6 Million - $2.85 Million	-17,571 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	17,571	17,571 $2.26 Million

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Vertex Pharmaceuticals Inc Transaction History